CIK 0001041024
- Non-accelerated filer
- Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383317208
- Phone
- +1 800-449-3353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- 4 Exercise or conversion Chairman, President and CEO acquired 375,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
- 4 Open-market sale Director sold 12,500 shares at an average $10.58 ($132,273)
- 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
- 4 Open-market sale Director sold 7,934 shares at an average $8.85 ($70,243)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4/A Insider Changes in Ownership
- 4/A Exercise or conversion Director acquired 12,500 shares (option exercise)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Vice President, CFO acquired 150,000 shares (grant or award)
- 4 Grant or award Chairman, President and CEO acquired 325,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 165,000 shares (grant or award)
- 4 Grant or award VP of Drug Development acquired 165,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Open-market buy Chairman, President and CEO bought 4,910 shares at $11.96 ($58,724)
- 4 Open-market buy Chief Scientific Officer bought 5,000 shares at an average $11.62 ($58,112)
- 4 Open-market buy VP of Drug Development bought 5,000 shares at an average $11.54 ($57,675)
- 4 Open-market buy Chairman, President and CEO bought 5,090 shares at an average $11.51 ($58,598)
- 4 Shares withheld for taxes VP of Drug Development gave up 34,650 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President, CFO gave up 27,440 shares (to pay taxes)
Page 12 of 24 · 470 filings